Safety and efficacy of endoscopic spray cryotherapy for esophageal cancer

Franklin C. Tsai, Shireen Ghorbani, Bruce D. Greenwald, Sunguk Jang, John A. Dumot, Matthew J. McKinley, Fadlallah Habr, Herbert C. Wolfsen, Julian A. Abrams, Charles J. Lightdale, Norman S. Nishioka, Mark H. Johnston, Alvin Zfass, Walter J. Coyle

Research output: Contribution to journalArticle

7 Scopus citations

Abstract

Although surgery is traditionally the standard of care for esophageal cancer, esophagectomy carries significant morbidity. Alternative endoscopic therapies are needed for patients who are not candidates for conventional treatment. The objective of this study is to assess the safety, efficacy, and tolerability of spray cryotherapy of esophageal adenocarcinoma. This study includes patients with esophageal adenocarcinoma who had failed or were not candidates for conventional therapy enrolled retrospectively and prospectively in an open-label registry and patients in a retrospective cohort from 11 academic and community practices. Endoscopic spray cryotherapy was performed until biopsy proven local tumor eradication or until treatment was halted due to progression of disease, patient withdrawal or comorbidities. Eighty-eight patients with esophageal adenocarcinoma (median age 76, 80.7% male, mean length 5.1 cm) underwent 359 treatments (mean 4.4 per patient). Tumor stages included 39 with T1a, 25 with T1b, 9 with unspecified T1, and 15 with T2. Eighty-six patients completed treatment with complete response of intraluminal disease in 55.8%, including complete response in 76.3% for T1a, 45.8% for T1b, 66.2% for all T1, and 6.7% for T2. Mean follow-up was 18.4 months. There were no deaths or perforations related to spray cryotherapy. Strictures developed in 12 of 88 patients (13.6%) but were present before spray cryotherapy in 3 of 12. This study suggests that endoscopic spray cryotherapy is a safe, well-tolerated, and effective treatment option for early esophageal adenocarcinoma.

Original languageEnglish (US)
Pages (from-to)1-7
Number of pages7
JournalDiseases of the Esophagus
Volume30
Issue number11
DOIs
StatePublished - Nov 1 2017
Externally publishedYes

Keywords

  • Cryo
  • Cryotherapy
  • Endoscopic therapy
  • Endoscopy
  • Esophageal cancer

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Safety and efficacy of endoscopic spray cryotherapy for esophageal cancer'. Together they form a unique fingerprint.

  • Cite this

    Tsai, F. C., Ghorbani, S., Greenwald, B. D., Jang, S., Dumot, J. A., McKinley, M. J., Habr, F., Wolfsen, H. C., Abrams, J. A., Lightdale, C. J., Nishioka, N. S., Johnston, M. H., Zfass, A., & Coyle, W. J. (2017). Safety and efficacy of endoscopic spray cryotherapy for esophageal cancer. Diseases of the Esophagus, 30(11), 1-7. https://doi.org/10.1093/dote/dox087